Idecabtagene vicleucel (Abecma)

This topic covers idecabtagene vicleucel, also known as Abecma, a personalized treatment for multiple myeloma. To create this therapy, your care team collects white blood cells from your blood, alters them in a laboratory to help them recognize myeloma cells, and gives them back to you through a single intravenous (IV) infusion. Learning about this process helps you understand each step of the treatment timeline, including cell collection, manufacturing time, and recovery. In this space, you can find information on preparing for the infusion, managing common side effects, and hearing how other patients and caregivers navigate daily life with this therapy.